TY  - JOUR
PY  - 2023//
TI  - Pharmacotherapy may attenuate the risk of child abuse in attention-deficit/hyperactivity disorder from the real-world evidence
JO  - Journal of child and adolescent psychopharmacology
A1  - Lin, Cian-Cian
A1  - Chung, Chi-Hsiang
A1  - Chien, Wu-Chien
A1  - Tzeng, Nian-Sheng
SP  - 59
EP  - 68
VL  - 33
IS  - 2
N2  - OBJECTIVE: Psychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD), may serve as a risk factor for child abuse. <br><br>METHODS: This study aimed to evaluate the association between children and adolescents with ADHD diagnosis and the risk of child abuse. The effectiveness of a pharmacological intervention on reducing the risk of child abuse was also assessed. A nationwide, population-based, retrospective with a matched-cohort study design was used. Data were from the National Health Insurance Research Database of Taiwan over a 15-year period (2000-2015). <br><br>RESULTS: Increased risk of child abuse in the ADHD group was noticed and the adjusted hazard ratio (HR) was 1.797 (95% confidence interval [CI] = 1.245-2.388, p < 0.001). The Kaplan-Meier analysis showed a significantly higher cumulative incidence in the ADHD group over the 15-year period (Log-rank test p < 0.001). ADHD patients with other psychiatric comorbidities had a higher risk of child abuse. Pharmacological treatment of either methylphenidate or atomoxetine was associated with a reduced risk of child abuse. The total adjusted HR was 1.466 (95% CI = 1.077-1.883, p < 0.001) in medicine group compared with the controls. <br><br>CONCLUSIONS: ADHD was associated with a subsequent risk of child abuse in Taiwan. Pharmacological treatment could reduce the risk of child abuse in ADHD patients.<p />  <p>Language: en</p>
LA  - en
SN  - 1044-5463
UR  - http://dx.doi.org/10.1089/cap.2023.0003
ID  - ref1
ER  -